Privium Fund Management B.V. / DNLI
Privium Fund Management B.V.’s Denali Therapeutics Inc Position
Does Privium Fund Management B.V. own Denali Therapeutics Inc (DNLI)? Yes — 254.9K shares worth $5M (+1.02% of its 13F portfolio) as of Q1 2026.
Position Value
$5M
Q1 2026
Shares
254.9K
% of Portfolio
+1.02%
Quarters Held
1
currently held
Position History DNLI
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 254.9K | $5M | +1.02% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Privium Fund Management B.V.’s full portfolio or all institutional holders of DNLI.